| Serial Number | 79329638 |
| Word Mark | ABOGENBIO |
| Filing Date | Monday, November 1, 2021 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Wednesday, June 25, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, November 22, 2022 |
| Description of Mark | The mark consists of the stylized wording "ABOGENBIO". |
| Goods and Services | Pharmaceutical preparations for the treatment or prevention of cancer, and infectious diseases; chemico-pharmaceutical preparations for the treatment or prevention of cancer and infectious diseases; drugs being pharmaceutical preparations for medical purposes for the treatment or prevention of cancer and infectious diseases; biological preparations for the treatment or prevention of cancer and infectious diseases for medical purposes; medicines for the treatment or prevention of cancer and infectious diseases for human purposes; chemical preparations for medical purposes, namely, for the treatment or prevention of cancer and infectious diseases; crude drug being homeopathic pharmaceuticals for the treatment of infectious viral diseases;, lipid particle for nucleotide drug delivery purpose for the treatment or prevention of cancer and infectious diseases; and biochemical medicines for the treatment or prevention of cancer and infectious diseases; dietetic substances being foods and beverages adapted for medical use for the treatment or prevention of cancer and infectious diseases |
| Goods and Services | Technological research in the field of medical research, specifically for the treatment or prevention of cancer and infectious diseases; quality control, specifically for products for the treatment or prevention of cancer and infectious disease; product quality testing, specifically for products for the treatment or prevention of cancer and infectious diseases; cancer research for medical purposes; pharmaceutical drug development services, specifically for pharmaceutical drugs for the treatment or prevention of cancer and infectious diseases; pharmaceutical product evaluation, namely, drug evaluation, specifically for the treatment or prevention of cancer and infectious diseases; pharmaceutical research services, specifically for products for the treatment or prevention of cancer and infectious diseases; medical research, specifically for the treatment or prevention of cancer and infectious diseases; development of pharmaceutical preparations and pharmaceuticals, specifically for products for the treatment or prevention of cancer and infectious diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 3, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 3, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Suzhou Abogen Biosciences Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Party Name | Suzhou Abogen Biosciences Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, December 30, 2021 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, January 3, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, August 10, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, August 23, 2022 | REFUSAL PROCESSED BY MPU |
| Tuesday, August 23, 2022 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, September 12, 2022 | REFUSAL PROCESSED BY IB |
| Friday, January 7, 2022 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, August 16, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, August 17, 2022 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Tuesday, October 18, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 18, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 18, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, October 18, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 22, 2022 | PUBLISHED FOR OPPOSITION |
| Thursday, December 15, 2022 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, March 22, 2023 | OPPOSITION NOTICE (IB REFUSAL) CREATED |
| Wednesday, March 22, 2023 | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB |
| Tuesday, November 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, March 27, 2023 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, May 31, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB |
| Wednesday, May 31, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Monday, June 19, 2023 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Tuesday, June 24, 2025 | OPPOSITION DISMISSED NO. 999999 |
| Tuesday, June 24, 2025 | OPPOSITION TERMINATED NO. 999999 |
| Tuesday, June 24, 2025 | TTAB RELEASE CASE TO TRADEMARKS |
| Wednesday, April 19, 2023 | REFUSAL PROCESSED BY IB |